IL220845A - 6-amino-2 - {[(1 s) –1– methylbutyl] oxy} –9– [5– (1-piperidinyl) pentyl] –9,7 – dihydro-8 h– purine-8 – and malt - Google Patents

6-amino-2 - {[(1 s) –1– methylbutyl] oxy} –9– [5– (1-piperidinyl) pentyl] –9,7 – dihydro-8 h– purine-8 – and malt

Info

Publication number
IL220845A
IL220845A IL220845A IL22084512A IL220845A IL 220845 A IL220845 A IL 220845A IL 220845 A IL220845 A IL 220845A IL 22084512 A IL22084512 A IL 22084512A IL 220845 A IL220845 A IL 220845A
Authority
IL
Israel
Prior art keywords
purin
methylbutyl
piperidinyl
maleate
dihydro
Prior art date
Application number
IL220845A
Other languages
English (en)
Hebrew (he)
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of IL220845A publication Critical patent/IL220845A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
IL220845A 2010-02-10 2012-07-10 6-amino-2 - {[(1 s) –1– methylbutyl] oxy} –9– [5– (1-piperidinyl) pentyl] –9,7 – dihydro-8 h– purine-8 – and malt IL220845A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30301010P 2010-02-10 2010-02-10
PCT/EP2011/051830 WO2011098452A1 (en) 2010-02-10 2011-02-08 6-amino-2-{ [ (1s)-1-methylbutyl] oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8h-purin-8-one maleate

Publications (1)

Publication Number Publication Date
IL220845A true IL220845A (en) 2016-08-31

Family

ID=43836817

Family Applications (1)

Application Number Title Priority Date Filing Date
IL220845A IL220845A (en) 2010-02-10 2012-07-10 6-amino-2 - {[(1 s) –1– methylbutyl] oxy} –9– [5– (1-piperidinyl) pentyl] –9,7 – dihydro-8 h– purine-8 – and malt

Country Status (23)

Country Link
US (1) US8703754B2 (cg-RX-API-DMAC7.html)
EP (1) EP2534149B1 (cg-RX-API-DMAC7.html)
JP (1) JP5922587B2 (cg-RX-API-DMAC7.html)
KR (1) KR101773541B1 (cg-RX-API-DMAC7.html)
CN (1) CN102753553B (cg-RX-API-DMAC7.html)
AU (1) AU2011214468B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012018904A2 (cg-RX-API-DMAC7.html)
CA (1) CA2786973C (cg-RX-API-DMAC7.html)
DK (1) DK2534149T3 (cg-RX-API-DMAC7.html)
EA (1) EA021048B1 (cg-RX-API-DMAC7.html)
ES (1) ES2525826T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20141258T1 (cg-RX-API-DMAC7.html)
IL (1) IL220845A (cg-RX-API-DMAC7.html)
ME (1) ME01926B (cg-RX-API-DMAC7.html)
MX (1) MX2012009316A (cg-RX-API-DMAC7.html)
PL (1) PL2534149T3 (cg-RX-API-DMAC7.html)
PT (1) PT2534149E (cg-RX-API-DMAC7.html)
RS (1) RS53745B1 (cg-RX-API-DMAC7.html)
SG (1) SG182471A1 (cg-RX-API-DMAC7.html)
SI (1) SI2534149T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201400196B (cg-RX-API-DMAC7.html)
WO (1) WO2011098452A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201205995B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA103195C2 (uk) 2008-08-11 2013-09-25 Глаксосмитклайн Ллк Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
AU2009323766B2 (en) 2008-12-02 2016-10-06 Wave Life Sciences Ltd. Method for the synthesis of phosphorus atom modified nucleic acids
SG177564A1 (en) 2009-07-06 2012-02-28 Ontorii Inc Novel nucleic acid prodrugs and methods of use thereof
SI2491035T1 (sl) 2009-10-22 2017-10-30 Gilead Sciences, Inc. Derivati purina ali deazapurina uporabni za zdravljenje (med drugimi) virusnih okužb
EP2620428B1 (en) 2010-09-24 2019-05-22 Wave Life Sciences Ltd. Asymmetric auxiliary group
US9605019B2 (en) 2011-07-19 2017-03-28 Wave Life Sciences Ltd. Methods for the synthesis of functionalized nucleic acids
SMT201800642T1 (it) * 2011-07-22 2019-01-11 Glaxosmithkline Llc Composizione
JP6246121B2 (ja) * 2012-07-13 2017-12-13 株式会社新日本科学 キラル核酸アジュバント
SG10201912895PA (en) 2012-07-13 2020-02-27 Wave Life Sciences Ltd Chiral control
JP6268157B2 (ja) 2012-07-13 2018-01-24 株式会社Ｗａｖｅ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｊａｐａｎ 不斉補助基
HK1211029A1 (en) 2012-08-24 2016-05-13 Glaxosmithkline Llc Pyrazolopyrimidine compounds
EP2922547B1 (en) 2012-11-20 2017-03-08 Glaxosmithkline LLC Novel compounds
AU2013348217B2 (en) 2012-11-20 2016-10-06 Glaxosmithkline Llc Novel compounds
SMT201700378T1 (it) 2012-11-20 2017-09-07 Glaxosmithkline Llc Nuovi composti
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
JPWO2015108047A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
EP3095460A4 (en) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
PT3094728T (pt) 2014-01-16 2022-05-19 Wave Life Sciences Ltd Desenho quiral
WO2016033540A1 (en) * 2014-08-29 2016-03-03 Corium International, Inc. Microstructure array for delivery of active agents
US10584125B2 (en) * 2014-11-13 2020-03-10 Glaxosmithkline Biologicals Sa Adenine derivatives which are useful in the treatment of allergic diseases or other inflammatory conditions
US12130267B2 (en) * 2018-11-28 2024-10-29 Shimadzu Corporation Analyzing method for azo compound
KR20250106231A (ko) 2023-12-29 2025-07-09 (주)셀트리온 안정한 약제학적 제제

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB427857A (en) 1934-08-02 1935-05-01 Newsum Sons & Company Ltd H A new or improved system of construction for skeleton structures, particularly vehicle body frames and door frames
ES2122261T3 (es) 1993-03-17 1998-12-16 Minnesota Mining & Mfg Formulacion de aerosol que contiene un adyuvante de dispersion derivado de un ester, una amida o un mercaptoester.
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
CA2310896A1 (en) 1999-07-02 2001-01-02 Japan Tobacco Inc. Hcv polymerase suitable for crystal structure analysis and method for using the enzyme
NZ514403A (en) 1999-12-27 2002-10-25 Japan Tobacco Inc Fused-ring compounds and use thereof as drugs
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
US6310224B1 (en) 2001-01-19 2001-10-30 Arco Chemical Technology, L.P. Epoxidation catalyst and process
BR0206614A (pt) 2001-01-22 2004-02-17 Merck & Co Inc Composto, composição farmacêutica, método para inibir a polimerase viral de rna dependente de rna e/ou inibir a replicação viral de rna dependente de rna, método para tratar uma infecção viral de rna dependente de rna, e, uso de um composto
CA2441162A1 (en) 2001-03-19 2002-09-26 Ono Pharmaceutical Co., Ltd. Pharmaceutical composition comprising, as an active ingredient, triazaspiro[5.5]undecane derivative
AR035543A1 (es) 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
CA2448737C (en) 2001-07-20 2010-06-01 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
AU2003260578A1 (en) 2002-04-04 2003-10-20 Achillion Pharmaceuticals, Inc. Hcv antiviral and cytotoxicity drug screening assay
DOP2003000641A (es) 2002-05-10 2003-11-15 Pfizer Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan
AU2003276172A1 (en) 2002-10-24 2004-05-13 Glaxo Group Limited 1-acyl-pyrrolidine derivatives for the treatment of viral infections
AU2003300902A1 (en) 2002-12-13 2004-07-09 Smithkline Beecham Corporation Piperidine derivatives as CCR5 antagonists
AU2003297048A1 (en) 2002-12-13 2004-07-09 Smithkline Beecham Corporation Cyclohexyl compounds as ccr5 antagonists
DE60322423D1 (de) 2002-12-13 2008-09-04 Smithkline Beecham Corp Pyrrolidin- und azetidinverbindungen alsccr5-antagonisten
WO2004055012A1 (en) 2002-12-13 2004-07-01 Smithkline Beecham Corporation Indane compounds as ccr5 antagonists
AU2003296993A1 (en) 2002-12-13 2004-07-09 Smithkline Beecham Corporation Cyclopropyl compounds as ccr5 antagonists
WO2004055011A1 (en) 2002-12-13 2004-07-01 Smithkline Beecham Corporation Heterocyclic compounds as ccr5 antagonists
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7148226B2 (en) 2003-02-21 2006-12-12 Agouron Pharmaceuticals, Inc. Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
WO2005014543A1 (ja) 2003-08-06 2005-02-17 Japan Tobacco Inc. 縮合環化合物及びそのｈｃｖポリメラーゼ阻害剤としての利用
EP1699512B1 (en) 2003-11-03 2012-06-20 Glaxo Group Limited A fluid dispensing device
UY28758A1 (es) 2004-02-20 2005-09-30 Boehringer Ingelheim Int Inhibidores de polimerasa viral
EP1748991A1 (en) 2004-04-28 2007-02-07 Arrow Therapeutics Limited Morpholinylanilinoquinazo- line derivatives for use as antiviral agents
US7153848B2 (en) 2004-08-09 2006-12-26 Bristol-Myers Squibb Company Inhibitors of HCV replication
PT1781662E (pt) 2004-08-18 2011-07-01 Pfizer Inibidores de rna polimerase dependendte de rna do vírus da hepatitie c e composições e tratamentos usando os mesmos
US20060045885A1 (en) 2004-08-27 2006-03-02 Kedl Ross M Method of eliciting an immune response against HIV
GB0423673D0 (en) 2004-10-25 2004-11-24 Glaxo Group Ltd Compounds
CN101247807A (zh) 2005-05-09 2008-08-20 艾其林医药公司 噻唑化合物及使用方法
JPWO2007034881A1 (ja) 2005-09-22 2009-03-26 大日本住友製薬株式会社 新規アデニン化合物
GB0610666D0 (en) 2006-05-30 2006-07-05 Glaxo Group Ltd Fluid dispenser
ATE490249T1 (de) 2007-02-19 2010-12-15 Glaxosmithkline Llc Purinderivate als immunmodulatoren
DK2132209T3 (da) * 2007-03-19 2014-04-14 Astrazeneca Ab 9-substituerede 8-oxo-adeninforbindelser som modulatorer af tlr7 (toll-like receptor 7)
UY31531A1 (es) * 2007-12-17 2009-08-03 Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
US8777708B2 (en) 2008-06-27 2014-07-15 Microsoft Corporation Targeting control in a simulated environment
UA103195C2 (uk) * 2008-08-11 2013-09-25 Глаксосмитклайн Ллк Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань

Also Published As

Publication number Publication date
EP2534149A1 (en) 2012-12-19
EA021048B1 (ru) 2015-03-31
MX2012009316A (es) 2012-09-12
CN102753553A (zh) 2012-10-24
US8703754B2 (en) 2014-04-22
ME01926B (me) 2015-05-20
WO2011098452A1 (en) 2011-08-18
ZA201205995B (en) 2014-01-29
SG182471A1 (en) 2012-08-30
AU2011214468B2 (en) 2015-05-28
RS53745B1 (sr) 2015-06-30
ES2525826T3 (es) 2014-12-30
HRP20141258T1 (hr) 2015-02-27
BR112012018904A2 (pt) 2020-09-01
DK2534149T3 (da) 2015-01-05
US20120308609A1 (en) 2012-12-06
PT2534149E (pt) 2014-12-23
SI2534149T1 (sl) 2015-02-27
SMT201400196B (it) 2015-01-15
AU2011214468A1 (en) 2012-08-09
EA201290631A1 (ru) 2013-03-29
KR101773541B1 (ko) 2017-08-31
JP2013519645A (ja) 2013-05-30
CA2786973A1 (en) 2011-08-18
CN102753553B (zh) 2016-03-30
EP2534149B1 (en) 2014-10-15
CA2786973C (en) 2018-04-10
JP5922587B2 (ja) 2016-05-24
KR20120135408A (ko) 2012-12-13
PL2534149T3 (pl) 2015-03-31

Similar Documents

Publication Publication Date Title
IL220845A (en) 6-amino-2 - {[(1 s) –1– methylbutyl] oxy} –9– [5– (1-piperidinyl) pentyl] –9,7 – dihydro-8 h– purine-8 – and malt
EP2624698A4 (en) Furo [3,2-D] PYRIMIDINE COMPOUNDS
IL237471A (en) Annals of [[(s1) –2– isopropoxy – 1 – methyl – 2 – oxo-ethyl] amino] –phenoxy – phosphoryl
EP2589897A4 (en) Touch-control multifunctional refrigerating cup holder
ZA201105352B (en) Novel benzodiazepine derivatives
EP2507763A4 (en) LOCATION BASED SEARCH
WO2011163332A9 (en) Methods for detecting cancer
GB0904171D0 (en) Cyclonic separator
SI2473053T1 (sl) Substiturani derivati ksantina
EP2524552A4 (en) Wireless sensor synchronization methods
ZA201209029B (en) Novel pyrimidine derivatives
IL233282A0 (en) Manufacturing process for pyrimidine history
EP2408303A4 (en) MORPHINANE DERIVATIVES HAVING HIGH ORAL BIOLOGICAL AVAILABILITY
ZA201204429B (en) Ethynyl derivatives
EP2616477A4 (en) 6-SUBSTITUTED DEMETHYL-ESTRADIOL DERIVATIVES AS ER-BETA AGONISTS
IL212942A0 (en) Rifamycin derivatives
EP2539914A4 (en) Ac interconnect scheme for psu
IL220307A0 (en) New secondary 8-hydroxyquinoline-7-carboxamide derivatives
ZA201105528B (en) 2-morpholino-pyrido[3,2-d]pyrimidines
AU2009904914A0 (en) Clothing for infants
AU2010101360A4 (en) Kiteboarding Dual Board Bag
AU2013204145B2 (en) Pure erlotinib
AU2010901004A0 (en) Garment for ostymates
GB0902733D0 (en) Complex pants
AU2008905196A0 (en) Clothing for infants

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees